프로바이오틱스 원료 시장 보고서 : 원료, 형태, 용도, 지역별(2025-2033년)

The global probiotic ingredients market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.2 Billion by 2033, exhibiting a growth rate (CAGR) of 4.99% during 2025-2033. The growing consumer inclination towards improving gut health and overall well-being is stimulating the market.

Probiotics refer to live microorganisms consumed for improving the functioning of the digestive system. Also known as good or healthy bacteria, they help prevent diseases related to oral health, bacterial vaginosis, and urinary tract infection. They also aid in preventing ailments such as respiratory infections, necrotizing enterocolitis, and bowel diseases. Probiotic ingredients are available in the form of capsules, tablets, powder, and liquid, as well as found in fermented food products containing live-active cultures, such as yogurt, kefir, sourdough bread, sauerkraut, tempeh, and kimchi. When consumed in the form of supplements, probiotics colonize the gut with health-boosting microorganisms and stops undesirable bacteria from overgrowing in the digestive tract. They are also suggested by doctors as they help in reducing depression and promote heart health.

Probiotic Ingredients Market Trends:

The global probiotic ingredients market is primarily driven by the increasing awareness among individuals regarding preventive healthcare, which has resulted in the rising expenditure on probiotic products. This trend has further been boosted by the spread of the coronavirus disease (COVID-19) pandemic, which has increased the focus toward strengthening immunity. The growing prevalence of gut-related diseases, especially among the geriatric population, is also propelling the market growth. In countries such as Japan, Germany, and the United States, probiotic-based dietary supplements are widely consumed, and probiotic food products have become a part of the food culture. Factors such as increasing disposable incomes and the changing attitude toward preventive healthcare, coupled with the easy availability of information on the internet, are positively influencing the growth of the market. Furthermore, market players are launching new products in convenient packaging formats made with superior quality ingredients.

Key Market Segmentation:

Breakup by Ingredient:

• Bacteria
• Yeast
• Spore Formers

Breakup by Form:

• Liquid
• Dry

Breakup by Application:

• Food and Beverages
• Dietary Supplements
• Animal Feed Probiotic

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzyme Technologies Limited, Biena, Biogaia, Chr. Hansen Holding AS, Danone Inc., Deerland Probiotics & Enzymes Inc., DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM NV and Lallemand Inc.

Key Questions Answered in This Report

• 1.What was the size of the global probiotic ingredients market in 2024?
• 2.What is the expected growth rate of the global probiotic ingredients market during 2025-2033?
• 3.What are the key factors driving the global probiotic ingredients market?
• 4.What has been the impact of COVID-19 on the global probiotic ingredients market growth?
• 5.What is the breakup of the global probiotic ingredients market based on the ingredient?
• 6.What is the breakup of the global probiotic ingredients market based on the form?
• 7.What is the breakup of the global probiotic ingredients market based on the application?
• 8.What are the key regions in the global probiotic ingredients market?
• 9.Who are the key players/companies in the global probiotic ingredients market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Probiotic Ingredients Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Ingredient

• 6.1 Bacteria
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Yeast
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Spore Formers
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Form

• 7.1 Liquid
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Dry
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Food and Beverages
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Dietary Supplements
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Animal Feed Probiotic
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Advanced Enzyme Technologies Limited
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
  • 14.3.2 Biena
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Biogaia
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Chr. Hansen Holding AS
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Danone Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Deerland Probiotics & Enzymes Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 DuPont de Nemours Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Kerry Group plc
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Koninklijke DSM NV
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Lallemand Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio